Document is current
Any future updates will be listed below
-
Authors
Amano, Akiko
Sanjo, Nobuo
Araki, Wataru
Anraku, Yasutaka
Nakakido, Makoto
Matsubara, Etsuro
Tomiyama, Takami
Nagata, Tetsuya
Tsumoto, Kouhei
Kataoka, Kazunori
Yokota, Takanori
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (KAKENHI grant 19K07836)
Japan Society for the Promotion of Science (KAKENHI grant 20K07798)
Japan Agency for Medical Research and Development (18dm0107063h0003)
Japan Agency for Medical Research and Development (JP19dm0107063h0004)
Japan Agency for Medical Research and Development (JP20dm0107063h0005)
- License Information
-
More Information
Article History
Received: 13 June 2022
Accepted: 7 January 2023
First Online: 31 January 2023
Declarations
:
: All animal experiments were approved by the Guidelines for the Care and Use of Laboratory Animals, as stated by the iCONM (Innovation Center of NanoMedicine, Kawasaki, Japan) [Approval Number: G15-009-6]. All biochemical experiments were approved by the Research Safety Control Office for Gene Recombinant Organisms of Tokyo Medical and Dental University (TMDU) [Approval Number: G2018-012C7]. As client-owned animals were not used in this study, consent to participate was not required.
: Not applicable.
: The authors declare that they have no competing interests.
